Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:ASNBNASDAQ:NVIVOTCMKTS:RGINOTCMKTS:UAHC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASNBEKIMAS$0.61$0.56$0.55▼$1.75$3.54M0.373,162 shsN/ANVIVInVivo Therapeutics$0.58$0.22▼$2.40$997K0.658.25 million shs1.89 million shsRGINRegenicin$0.01$0.00$0.00▼$0.01$830KN/A7,333 shsN/AUAHCUnited American Healthcare$0.03$0.03$0.02▼$0.05$3.11M-1.422,833 shsN/A12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASNBEKIMAS0.00%0.00%0.00%+12.96%-22.78%NVIVInVivo Therapeutics0.00%0.00%0.00%-52.32%-75.89%RGINRegenicin0.00%0.00%+4,900.00%+4,900.00%+233.33%UAHCUnited American Healthcare0.00%+2.40%-10.50%+2.40%+66.41%top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASNBEKIMASN/AN/AN/AN/AN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASNBEKIMASN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASNBEKIMASN/AN/AN/AN/A$0.03 per shareN/ANVIVInVivo TherapeuticsN/AN/AN/AN/A$6.48 per shareN/ARGINRegenicinN/AN/AN/AN/A($0.04) per shareN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASNBEKIMAS-$290KN/A0.00∞N/AN/A-7,902.31%-5,274.01%N/ANVIVInVivo Therapeutics-$10.49MN/A0.00N/AN/AN/A-75.04%-65.01%N/ARGINRegenicin-$640KN/A0.00∞N/AN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASNBEKIMASN/AN/AN/AN/AN/ANVIVInVivo TherapeuticsN/AN/AN/AN/AN/ARGINRegenicinN/AN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASNBEKIMASN/A0.120.12NVIVInVivo TherapeuticsN/A14.3014.30RGINRegenicinN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipASNBEKIMASN/ANVIVInVivo Therapeutics13.78%RGINRegenicin0.01%UAHCUnited American HealthcareN/AInsider OwnershipCompanyInsider OwnershipASNBEKIMAS7.80%NVIVInVivo Therapeutics2.45%RGINRegenicinN/AUAHCUnited American Healthcare14.31%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableASNBEKIMAS115.80 million5.35 millionNot OptionableNVIVInVivo Therapeutics63.11 million3.03 millionNot OptionableRGINRegenicin3165.77 millionN/ANot OptionableUAHCUnited American Healthcare33117.06 million100.31 millionNot OptionableNVIV, ASNB, RGIN, and UAHC HeadlinesSourceHeadlineChange Healthcare cyberattack updates detail massive impact, costscomplianceweek.com - April 24 at 12:42 AMFTC votes 3-2 to ban non-compete clauses for American workersmsn.com - April 23 at 7:42 PMPatient Data Compromised - UnitedHealth Group Admits Ransom Payment in Cyberattackmsn.com - April 23 at 7:42 PMEMPOWERING WOMEN: pH-D FEMININE HEALTH'S COMMITMENT TO VAGINAL WELLNESSfinance.yahoo.com - April 23 at 2:42 PMUnitedHealth paid ransom after massive Change Healthcare cyberattackmsn.com - April 23 at 2:42 PMUnitedHealth Group Previews Massive Change Healthcare Breachdatabreachtoday.com - April 23 at 9:41 AMUnitedHealth Reveals Biggest Cyberattack On American Healthcare System Affecting Millionsibtimes.com - April 23 at 9:41 AMUnited Health CEO to face House panelthehill.com - April 19 at 6:30 PMDow's 265-point rally led by gains in shares of American Express, UnitedHealthmarketwatch.com - April 19 at 1:29 PMNational Minority Health Month; bringing awareness to health disparities and encouraging actionmsn.com - April 19 at 8:27 AMUnited American Healthcare (OTCMKTS:UAHC) Stock Price Crosses Below 200 Day Moving Average of $0.03americanbankingnews.com - April 19 at 4:04 AM$2M going to United Health Centers for physician training, retentionthebusinessjournal.com - April 17 at 6:41 PMUnitedHealth skips hearing in the wake of Change cyberattack, triggering call for subpoenastatnews.com - April 17 at 6:41 PMNew Phase Of Change Healthcare Attack Begins As Hackers Leak Datakffhealthnews.org - April 16 at 3:25 PMUnitedHealth says Change Healthcare cyberattack cost it $872 millionmsn.com - April 16 at 3:25 PMHacker gang claims it has Change Healthcare data from cyberattackbizjournals.com - April 15 at 8:09 AMKeep Alachua County Beautiful hosts 33rd annual ‘Great American Cleanup’msn.com - April 14 at 2:06 AMCrippling Cyberattack Brings U.S. HealthCare System to a Halttownhall.com - April 13 at 12:46 AM2024 American Lung Association’s Fight for Air Climbwgnradio.com - April 12 at 9:45 AMHuge health care hack exposed 144M Americans' info. Was your data exposed? Check heremsn.com - April 11 at 7:10 PMApril is National Minority Health Monthjournal-advocate.com - April 11 at 9:10 AMAMA: Four In Five Physicians ‘Lost Revenue’ From Change Healthcare Cyber Attackforbes.com - April 10 at 2:41 PMAMA: Four In Five Physicians ‘Lost Revenue’ From Change Healthcare Cyber Attackforbes.com - April 10 at 2:41 PMChange Healthcare Could Get Congress’ Attention Before Break for Electionajmc.com - April 6 at 8:24 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesBuy the Dip in Paychex, Inc. for a Pay Check at RetirementApril 2, 2024 11:07 AMView Buy the Dip in Paychex, Inc. for a Pay Check at RetirementBuy the Dip in Netflix Stock, It Won’t Last LongApril 19, 2024 8:32 AMView Buy the Dip in Netflix Stock, It Won’t Last LongBargain Hunting: 3 Stocks With RSIs That Scream OversoldApril 19, 2024 8:59 AMView Bargain Hunting: 3 Stocks With RSIs That Scream OversoldWD-40 Company Greases the Wheels of Growth and ProfitsApril 10, 2024 10:12 AMView WD-40 Company Greases the Wheels of Growth and ProfitsWalt Disney’s Proxy Tug of War Pulls Shares to 52-Week Highs April 1, 2024 9:02 AMView Walt Disney’s Proxy Tug of War Pulls Shares to 52-Week Highs All Headlines Company DescriptionsEKIMASOTCMKTS:ASNBEKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.InVivo TherapeuticsNASDAQ:NVIVInVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. It is in joint administration with InVivo Therapeutics Corporation.RegenicinOTCMKTS:RGINRegenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.United American HealthcareOTCMKTS:UAHCUnited American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.